<DOC>
	<DOCNO>NCT01074593</DOCNO>
	<brief_summary>The primary objective study compare pharmacokinetic pharmacodynamic effect two commercial preparation interferon beta-1a ( IFN Test : Lab Bergamo IFN Comparator : Rebif Â® - Merck Serono Lab ) single administration ( 12.000UI ) healthy subject modify parameter Cmax , Tmax AUC ( pharmacokinetics ) level 2 ' 5 ' oligoadenylate synthase beta-2-microglobulin ( pharmacodynamics ) .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Interferon Beta-1a Produced Laboratorio Quimico Farmaceutico Bergamo Compared Interferon Beta-1a ( Rebif - Merck Serono ) Healthy Subjects</brief_title>
	<detailed_description>Secondly , safety observe ( tolerability ) clinically administration single dose study subject , compare clinical laboratory parameter study incidence adverse event .</detailed_description>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>1 . Accepted Informed Consent 2 . Study subject male , age 18 50 year ; 3 . Research subject body mass index great equal 19 less equal 30 ; 4 . Subjects consider healthy , base analysis clinical history clinical laboratory data . 1 . Having donate lose 450 mL blood 6 month precede study ; 2 . Have participate experimental study ingest drug trial 12 month precede start study ; 3 . Having make regular use medication 4 week prior start study make use medication interfere pharmacokinetics / pharmacodynamics drug study week start study ; 4 . Have hospitalize reason , 8 week start study ; 5 . Demonstrate history alcohol abuse , drug , drug , consume alcohol within 48 hour prior period hospitalization ; 6 . Have history liver disease , renal , pulmonary , gastrointestinal , hematological psychiatric ; 7 . To present pressure etiology require pharmacological treatment ; 8 . Display history myocardial infarction , angina / heart failure .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>PHARMACOKINETICS AND PHARMACODYNAMICS OF DRUG INTERFERON BETA-1A</keyword>
</DOC>